These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 3010525)
21. Clinical studies with treated clotting factor concentrates. Colombo M; Mannucci PM Dev Biol Stand; 1987; 67():333-6. PubMed ID: 3038639 [TBL] [Abstract][Full Text] [Related]
22. Human retroviral env and gag polypeptides: serologic assays to measure infection. Kanner SB; Cheng-Mayer C; Geffin RB; Parks WP; Beltz GA; Arthur LO; Samuel KP; Papas TS J Immunol; 1986 Jul; 137(2):674-8. PubMed ID: 3014000 [TBL] [Abstract][Full Text] [Related]
23. HTLV III and hepatitis A and B serological markers among U.S. military venereal disease patients. James JJ; Morgenstern M; Hatten JA; Koch MA Mil Med; 1986 Apr; 151(4):193-8. PubMed ID: 3010187 [No Abstract] [Full Text] [Related]
24. HTLV-III antibody in intravenous drug abusers of metropolitan Barcelona, Spain. Tor J; Muga R; Argelagues E; Rey-Joly C; Foz M; Ribas-Mundó M Arch Intern Med; 1986 Apr; 146(4):805. PubMed ID: 3008680 [No Abstract] [Full Text] [Related]
25. [Prevalence of hepatitis B surface antigen and its antibody in hospitalized patients of 2 psychiatric hospitals]. Focaccia R; Veronesi R; Takeda A; Bazone JR; Rodrigues E; Mazza CC; Kimura RT; Feldman C Rev Inst Med Trop Sao Paulo; 1982; 24(6):385-7. PubMed ID: 7182915 [No Abstract] [Full Text] [Related]
26. Antibodies to HTLV-III/LAV in Venezuelan patients with acute malarial infections. Volsky DJ; Wu YT; Stevenson M; Dewhurst S; Sinangil F; Merino F; Rodriguez L; Godoy G N Engl J Med; 1986 Mar; 314(10):647-8. PubMed ID: 3511375 [No Abstract] [Full Text] [Related]
27. [Anti-HTLV-III in hemophilic patients in Barcelona]. Hernández Sánchez JM; Piqueras J; Vila M; Tusell J; Triginer J Sangre (Barc); 1985; 30(5):857-63. PubMed ID: 3003939 [No Abstract] [Full Text] [Related]
28. Pyoderma gangrenosum in a patient with HTLV-III antibody. Schwartz BK; Clendenning WE; Blasik LG Arch Dermatol; 1986 May; 122(5):508-9. PubMed ID: 3010887 [No Abstract] [Full Text] [Related]
29. Detection of antibody to HTLV-III by commercial kits. O'Shaughnessy MV; Benning BJ; Neumann PW CMAJ; 1985 Sep; 133(6):551, 555. PubMed ID: 2992733 [No Abstract] [Full Text] [Related]
30. Receptors for polymerized human serum albumin and other hepatitis B virus markers during acute hepatitis B--predictive value of the outcome of the disease. Mora I; Porres JC; Bartolome FJ; Hernandez Guio C; Gutiez J; Carreño V Hepatogastroenterology; 1986 Dec; 33(6):250-4. PubMed ID: 3026941 [TBL] [Abstract][Full Text] [Related]
31. [Infection by HTLV III virus in Chilean homosexuals of median and high socioeconomic levels]. Velasco M; Sepúlveda C; Hurtado C Rev Med Chil; 1986 Sep; 114(9):823-7. PubMed ID: 3033791 [No Abstract] [Full Text] [Related]
32. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis. Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717 [No Abstract] [Full Text] [Related]
33. Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus. Perrillo RP; Regenstein FG; Roodman ST Ann Intern Med; 1986 Sep; 105(3):382-3. PubMed ID: 3017169 [No Abstract] [Full Text] [Related]
34. [Viral markers of acute hepatitis]. Jirón MI; Armas Merino R; Ramón Soto J; Wolff C Rev Med Chil; 1982 Dec; 110(12):1234-6. PubMed ID: 7184111 [No Abstract] [Full Text] [Related]